You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 12, December 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Pediatrics
 •Neonatology and Infant Care
 •Hemangiomas
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Infantile Hemangiomas With Unusually Prolonged Growth Phase

A Case Series

Heather A. Brandling-Bennett, MD; Denise W. Metry, MD; Eulalia Baselga, MD; Anne W. Lucky, MD; Denise M. Adams, MD; Maria R. Cordisco, MD; Ilona J. Frieden, MD

Arch Dermatol. 2008;144(12):1632-1637.

Background  Most infantile hemangiomas (IHs) complete their proliferative growth phase before 9 months of age, but those with unusually prolonged growth create unique clinical challenges. We performed a retrospective case series of IHs with prolonged growth to further characterize these lesions and their treatment.

Observations  We identified 23 patients as having IHs with prolonged growth after 9 months of age, with growth to a mean age of 17 months. All of the IHs had a deep dermal to subcutaneous component, all had either segmental or indeterminate morphologic characteristics, and 39% involved the parotid gland. A total of 20 of 23 received prolonged treatment with systemic corticosteroids (mean duration of treatment, 11 months), and 9 of 20 received additional systemic therapies (vincristine sulfate and/or interferon alfa-2a or alfa-2b).

Conclusions  Prolonged growth was observed primarily in IHs with a deep component and segmental morphologic characteristics. Recognition of this subset of hemangiomas is important for clinicians, and further study of IHs may provide clues to their pathogenesis.


Author Affiliations: Department of Dermatology, Harvard Medical School, Boston, Massachusetts (Dr Brandling-Bennett); Departments of Dermatology and Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston (Dr Metry); Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain (Dr Baselga); Department of Dermatology (Dr Lucky) and Division of Hematology/Oncology (Dr Adams), Children's Hospital Medical Center of Cincinnati, Cincinnati, Ohio; Department of Dermatology, Hospital de Pediatria, J. P. Garrahan, Buenos Aires, Argentina (Dr Cordisco); and Departments of Dermatology and Pediatrics, University of California, San Francisco (Dr Frieden).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

This Month in Archives of Dermatology
Arch Dermatol. 2008;144(12):1554.
FULL TEXT  

Infantile Hemangiomas: How to Know When They Grow
Maurice A. M. van Steensel
Arch Dermatol. 2008;144(12):1650.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Infantile Hemangiomas with Prolonged Growth
Journal Watch Dermatology 2009;2009:1-1.
FULL TEXT  

Infantile Hemangiomas: How to Know When They Grow
van Steensel
Arch Dermatol 2008;144:1650-1650.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.